A few short years ago, I had no clue how fast things would change for the Previvor Community when I wrote this post about the need for smarter options to screen for, to treat, and to prevent cancer. Times are changing fast for...
It is well-known that women who carry a mutation in BRCA1 or BRCA2 are at high risk to develop breast cancer (50-85% lifetime risk) and ovarian cancer (15-60% lifetime risk). Because the screening options for ovarian cancer (transvaginal ultrasound, the blood test...
